Frequency of low-grade adverse events and quality of life during chemotherapy determine patients’ judgement about treatment in advanced-stage thoracic cancer

PURPOSE: In lung cancer, the preservation of well-being is warranted given the limited prognosis. Chemotherapy may negatively influence health-related quality of life (HRQoL) due to adverse events. However, patients’ judgement about this negative impact is not well understood. We examined the relati...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mol, Mark, Visser, Sabine, den Oudsten, Brenda L., Lodder, Paul, van Walree, Nico, Belderbos, Huub, Aerts, Joachim G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660482/
https://www.ncbi.nlm.nih.gov/pubmed/30690684
http://dx.doi.org/10.1007/s00520-019-4659-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660482/
https://www.ncbi.nlm.nih.gov/pubmed/30690684
http://dx.doi.org/10.1007/s00520-019-4659-x

Ejemplares similares